WARNER CHILCOTT COMPANY, LLC Fajardo Puerto Rico Terms for exchanging the LEO 80185 Body Indication with a New LEO ProductTerms for Exchanging the Leo 80185 Body Indication With a New Leo Product • August 7th, 2009 • Warner Chilcott LTD • Pharmaceutical preparations
Reference is made to the Master Agreement dated as of April 1, 2003 between Galen (Chemicals) Limited and LEO Pharma A/S (“LEO”) (the “Master Agreement”) as amended by Addendum I dated as of September 14, 2005 between Warner Chilcott Company, LLC (formerly Warner Chilcott Company, Inc.) (“WCCI”) and LEO (the “Addendum”) and to the License, Supply and Development Agreement dated as of September 14, 2005 between LEO and WCCI, as amended (the “DC Agreement”). In consideration of the covenants and agreements contained herein and notwithstanding anything to the contrary set forth in the Master Agreement, the Addendum and the DC Agreement, LEO and WCCI hereby agree as follows:
